Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
37
pubmed:dateCreated
2005-9-12
pubmed:abstractText
ELOVL4 (elongation of very long chain fatty acids 4) is a member of the ELO family of proteins involved in the biosynthesis of very long chain fatty acids. Protein truncation mutations in ELOVL4 have been identified in patients with autosomal dominant Stargardt-like macular degeneration. To determine whether a dominant negative mechanism is responsible for the autosomal dominant inheritance pattern of this disease, we studied the subcellular localization and interaction of wild type and mutant ELOVL4 in COS-7 and HEK 293T cultured cells by immunofluorescence and co-immunoprecipitation. Wild type ELOVL4 containing an endoplasmic reticulum retention sequence was localized to the endoplasmic reticulum as expected. In contrast, disease-associated C-terminal truncation ELOVL4 mutants accumulated as large inclusions exhibiting aggresome-like characteristics in a juxtanuclear position within COS-7 cells. When the wild type and mutant proteins were co-expressed incultured cells, wild type ELOVL4 co-purified with mutant ELOVL4 on an immunoaffinity column and co-localized with the mutant protein in aggresome-like inclusions adjacent to the nucleus. These results indicate that wild type and mutant ELOVL4 form a complex that exhibits an abnormal subcellular localization found for individually expressed mutant ELOVL4. From these studies, we conclude that disease-linked C-terminal truncation mutants of ELOVL4 exert a dominant negative effect on wild type ELOVL4, altering its subcellular localization. This dominant negative mechanism contributes to the autosomal dominant inheritance of Stargardt-like macular dystrophy.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
280
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
32521-30
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16036915-Amino Acid Motifs, pubmed-meshheading:16036915-Animals, pubmed-meshheading:16036915-Antibodies, Monoclonal, pubmed-meshheading:16036915-COS Cells, pubmed-meshheading:16036915-Cell Line, pubmed-meshheading:16036915-Cell Nucleus, pubmed-meshheading:16036915-Cells, Cultured, pubmed-meshheading:16036915-Centrifugation, Density Gradient, pubmed-meshheading:16036915-Chromatography, Gel, pubmed-meshheading:16036915-DNA, Complementary, pubmed-meshheading:16036915-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:16036915-Endoplasmic Reticulum, pubmed-meshheading:16036915-Eye Proteins, pubmed-meshheading:16036915-Genes, Dominant, pubmed-meshheading:16036915-Glycoside Hydrolases, pubmed-meshheading:16036915-Glycosylation, pubmed-meshheading:16036915-Humans, pubmed-meshheading:16036915-Immunoprecipitation, pubmed-meshheading:16036915-Macular Degeneration, pubmed-meshheading:16036915-Membrane Proteins, pubmed-meshheading:16036915-Microscopy, Fluorescence, pubmed-meshheading:16036915-Mutation, pubmed-meshheading:16036915-Oligosaccharides, pubmed-meshheading:16036915-Protein Structure, Tertiary, pubmed-meshheading:16036915-Retina, pubmed-meshheading:16036915-Retinal Diseases, pubmed-meshheading:16036915-Sucrose, pubmed-meshheading:16036915-Transfection, pubmed-meshheading:16036915-Vision, Ocular
pubmed:year
2005
pubmed:articleTitle
Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4.
pubmed:affiliation
Department of Biochemistry and Molecular Biology, Centre for Macular Research, University of British Columbia, Vancouver, Canada.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural